Alliance Global Partners Comments on Cresco Labs Q4 Earnings

Cresco Labs Inc. (OTCMKTS:CRLBF) – Analysts at Alliance Global Partners issued their Q4 2024 earnings per share estimates for shares of Cresco Labs in a note issued to investors on Wednesday, October 30th. Alliance Global Partners analyst A. Grey anticipates that the company will post earnings per share of ($0.01) for the quarter. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.15) per share.

Cresco Labs (OTCMKTS:CRLBF) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.15). Cresco Labs had a negative net margin of 23.07% and a negative return on equity of 17.03%. The company had revenue of $184.36 million for the quarter, compared to analysts’ expectations of $184.26 million.

A number of other research analysts also recently weighed in on the stock. Ventum Cap Mkts upgraded shares of Cresco Labs to a “strong-buy” rating in a research report on Friday, August 9th. Needham & Company LLC reiterated a “hold” rating on shares of Cresco Labs in a research report on Monday, August 12th. Finally, Roth Capital upgraded Cresco Labs from a “hold” rating to a “strong-buy” rating in a research report on Friday, August 9th. Two research analysts have rated the stock with a hold rating, two have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $2.50.

Cresco Labs Stock Performance

CRLBF opened at $1.52 on Friday. The firm has a fifty day moving average price of $1.62 and a 200 day moving average price of $1.75. Cresco Labs has a 1 year low of $1.11 and a 1 year high of $2.65. The stock has a market cap of $739.53 million, a P/E ratio of -2.97 and a beta of 1.86. The company has a debt-to-equity ratio of 1.76, a current ratio of 2.00 and a quick ratio of 1.30.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.